Send2Press Newswire
Sun, 11 May 2008 18:57:33 GMT
Eularis to Address Marketing Return at Japanese Pharmaceutical Marketing Excellence Conference
TOKYO and LONDON, U.K., May 12 (SEND2PRESS NEWSWIRE) -- Dr. Andree Bates, president of the New York and London-based pharmaceutical analytics company Eularis, will be delivering a presentation on how to tell if you are making the wrong marketing decision. The Pharmaceutical Marketing Excellence conference takes place in Tokyo, Japan.
 At 11:45 a.m. on Monday, 19 May 2008, Dr. Bates will deliver a presentation titled, "How to Tell if You are Making the Wrong Marketing Decision Using Marketing ROI." Bates will expose the limitations of current measurement techniques used to guide current marketing decisions. She will also provide attendees with ideas on how to put return measurements to work in making marketing decisions for their own pharmaceutical organizations.
Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates' leadership, Eularis issued three related research reports in the past year, including: "Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line," "Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?," and "Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence."
WHO: Eularis
WHAT: Presentation on How to Tell if You are Making the Wrong Marketing Decision Using Marketing ROI
WHEN: 19 May 2008 at 11:45 a.m. in Tokyo UTC (GMT + 9 hours)
WHERE: Pharmaceutical Marketing Excellence Conference: Conrad Hotel, Tokyo
About Eularis
Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions.
Co-headquartered in London and New York City, although working internationally, the company has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.
More information about Eularis: www.eularis.com.
All trademarks acknowledged.
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, Eularis pharma analytics, Pharmaceutical Marketing Excellence Conference
Mon, 12 May 2008 01:25:00 GMT
STG Launches Media Campaign for the First DNA Paternity Test in Major Retail Stores
TEMPE, Ariz., April 29 (SEND2PRESS NEWSWIRE) -- Identigene, an industry leader in DNA identification testing, has chosen STG Media Corp as their Agency of Record. Identigene is a simple and reliable DNA paternity test that is currently available in 4,500 retail locations nationwide. The test includes swabs for collecting samples from inside the cheek of a child, alleged father and mother, which are then packaged and mailed to the Identigene lab in Salt Lake City. Results of the test are reported online or by mail 3-5 business days after the samples arrive at the lab.
 "Identigene is a perfect candidate to build success by utilizing our wide array of services," said CEO of STG Media Corp, Thomas Lark. "Identigene is a unique product, with the proper consumer education behind them, they will be able to maximize retail sales. We are designing a TV, print and radio campaign that will not only inform consumers that the product is out there, but that will also demonstrate that the product actually works."
The Identigene television commercial is designed to connect with the millions of Americans who have questions about paternity. The commercial will also include a website address www.dnatesting.com where consumers can enter their zip code to find a local pharmacy that stocks the Identigene DNA Paternity Test Collection Kit.
Identigene, a Sorenson Genomics company, was founded in 1993 and was the first DNA testing laboratory in the world to commercially use modern STR technology for paternity testing. Identigene offers a full range of DNA testing services including tests used to determine paternity, siblingship and other familial relationships, as well as DNA tests for purposes of immigration, child custody, settling estates and other family-related situations. Additional information about Identigene and its DNA testing services is available by visiting www.dnatesting.com.
STG Media Corp., STG Retail Direct, and STG Interactive, LLC, work together to develop and execute strategic, national marketing campaigns. Based in Tempe, AZ, STG Media is a full-service advertising agency specializing in creative and media buying for print, television and radio. STG Retail Direct places products directly on the shelves of Wal-mart, Walgreens, CVS, Target, GNC, and thousands of grocery and convenience stores nationwide. Helping clients to maximize their ad dollars, STG works hand in hand with AmeriMex DSD, a master distributor and brand management company with capabilities to place products on the check-out counters in over 100,000 C-Stores in the USA with a proven market blitz program and also export products in mass to Mexico and Japan.
STG Interactive develops cutting-edge E-commerce solutions in addition to search engine optimization and search engine marketing. As the line between brand marketing and direct response blurs, brand advertisers move to be more accountable, and direct response marketers evaluate themselves from a brand perspective. STG helps clients navigate through the complex landscape of opportunities that exist within the context of modern, cross-media campaigns.
For more information about the STG family of companies, call toll-free: 866-834-4370 or visit our website pr.printad.info/15 (redirects to STG portal).
The World Responds to You.(TM)
For additional information and media queries, contact:
Jenelle Allen, STG Media Corp., (480) 699-6078.
All trademarks acknowledged.
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, Identigene DNA paternity test, STG Media Corp
Tue, 29 Apr 2008 10:50:22 GMT
Neotrope Selected to Provide Internet Marketing Solutions for Creative Commercial Financing Firm, Lease With Crystal
LOS ANGELES, Calif., April 25 (SEND2PRESS NEWSWIRE) -- Neotrope(R), a leading advertising, PR, and Internet Marketing firm established 1983, today announced it has been chosen by a cutting edge creative commercial finance company, Lease With Crystal (www.Leasewithcrystal.com), to provide promotion and brand development for their company and Website.
 As part of this program, Neotrope will provide its proven ContextEngine(R) search engine Deep-Linking Technology, first introduced in fall of 1996. "We've been searching for the proper vehicle to launch us onto the laptops and office desks of business owners for some time now, this absolutely shows us the way," said Crystal Riley, of the Lease With Crystal namesake.
About Lease With Crystal
Lease With Crystal brings a big business know-how and a friendly simplistic approach to their clients in the equipment leasing world. The goal is to help businesses stay competitive, and afford the equipment they need now. "All clients benefit from our skill of matching the right business with the perfect custom leasing program - regardless of the industry. From lasers to tractors, we make growth possible, all while saving cash flow," Riley says.
Lease With Crystal is a brand new company, established in 2008, affiliated with Lease One which has over 19 years of industry experience. More information on their Equipment Leasing programs can be found at: www.Leasewithcrystal.com/leasing.htm.
About Neotrope(R)
Based in Torrance California, Neotrope (www.neotrope.com) has been helping small-to-medium businesses and entertainment companies establish their brand and grow revenue since 1983. Neotrope has launched over 600 Websites since March of 1995 and has developed "patent worthy" proprietary solutions for Internet Marketing and search positioning. Send2Press(R) Newswire, a service of Neotrope, offers best-in-class affordable news distribution for small-to-medium businesses. Send2Press also leverages Neotrope's ContextEngine(R) press release optimization technologies and PRTRax(TM) reader tracking for business intelligence. 2008 marks the company's 25th Anniversary.
Neotrope President/CEO Christopher Simmons is a leading authority on press release optimization, an award-winning multimedia designer and journalist, and is a member of the Public Relations Society of America, and ASCAP. A noted technologist, Mr. Simmons is frequently interviewed by organizations like Entrepreneur(R), Chicago Post Tribune, PC World(R) and Trendwatch.
More information: Send2Press.com/services/internet_marketing.shtml.
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, business equipment leasing, Neotrope interactive marketing
Fri, 25 Apr 2008 16:36:57 GMT
Eularis to Address Making the Right Research Decision for ROI
The Link Between Research and Decisions on Bottom Line Return at 3rd Annual Pharmaceutical Market Research Summit
NEW YORK, N.Y. and LONDON, U.K., April 21 (SEND2PRESS NEWSWIRE) -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on Making the Right Research Decision for ROI - The Link Between Research and Decisions on Bottom Line Return, at 3rd Annual Pharmaceutical Market Research Summit.
At 11:45 a.m. on Tuesday 29 April 2008, Dr. Bates will deliver a presentation titled, "How to Tell if You Are Making the Right Research Decision for ROI - The Link Between Research and Decisions on Bottom Line Return."
Bates will challenge the conference attendees and will expose where both traditional market research and ROI can go wrong when used to guide marketing decisions return. She will also provide attendees with ideas on how to utilize market research data to provide input into ROI measurement for their marketing teams.
WHO: Eularis
WHAT: Presentation on Making the Right Research Decision for ROI - The Link Between Research and Decisions on Bottom Line Return
WHEN: 29 April 2008 at 11:45 a.m. EDT
WHERE: 3rd Annual Pharmaceutical Market Research Summit
Hyatt Regency at Penn's Landing, Philadelphia
Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates' leadership, Eularis issued three related research reports in the past year, including:
"Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line" (www.pharmamarketingroi.com),
"Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?" (http://www.pharmaindustrysfe.com/), and
"Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence" (http://www.patientadherenceroi.com/).
The 3rd Annual Pharmaceutical Market Research Summit takes place in Philadelphia. The summit program features detailed case studies from some of the industry's most prominent organizations and provides information needed to improve market research initiatives.
About Eularis
Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance.
Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Co-headquartered in London and New York City, the company has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.
For more information about Eularis, visit www.eularis.com.
All trademarks acknowledged.
 View This Release in Japanese (PDF)
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, Eularis pharmaceutical analytics, Pharmaceutical Market Research Summit
Mon, 21 Apr 2008 10:49:23 GMT
BidaBingers Sell Faster with Real Estate Auctions
MIAMI, Fla., April 16 (SEND2PRESS NEWSWIRE) -- The team at BidaBing Corporation (BidaBing.com) announces the launch of a new real estate auctioning application and nicknames their agent members "BidaBingers." REALTORS(R), buyers, lenders and sellers are all invited to list and bid on foreclosures, short sales, estate sales and other distressed properties.
 The site's first "no reserve" property auction ends on April 30, and is currently at $130,000. The property is located in Miami, Fla. and has a "Zestimate" (Zillow.com estimate) of $239,000.
With the real estate market in a slump, BidaBing.com claims that they can help to liquidate real estate, quickly and effectively.
According to a recent report, U.S. home foreclosure filings jumped 60 percent and bank seizures more than doubled in February as rates on adjustable mortgages rose and property owners were unable to sell or to refinance amid declining prices.
Rick Diaz, the company founder said, "The challenge in this market is to attract enough buyers. By combining traditional marketing methods with the Internet and offering conventional financing, we will get more local and international-qualified buyers to participate in the bidding. That will bring the highest sale price in any market."
A Site for More Eyes:
The web site not only helps buyers find properties, but it addresses the needs of the real estate agents and lenders as well -- a group that is feeling the effects of the market's decline, like no other.
Buyers and sellers who are not working with an agent at the time of registration may continue through the registration process. However, buyers are required to be registered under a BidaBing.com agent member before submitting a bid.
Agent members will assist buyers through the bidding, contract and financing process. BidaBing.com's lead system also refers sellers to agent members for assistance and counseling.
For lenders, the company plays a role in helping them liquidate assets and new loan origination.
The company's objective is to make it easier for distressed properties to be auctioned to the general public with better terms while allowing banks and agents to benefit from the BidaBing.com application as well.
"Throughout the country, people are losing their homes and banks are losing money. In the end, everyone is losing, including tax payers. When we help someone avoid foreclosure everyone wins," Diaz said.
Currently, there are members in five states: California, Florida, Idaho, New York and Oregon. Most members are in South Florida, where the first marketing efforts are being tested. The database continues to grow on a daily basis.
To test the site and learn about its potential, visit: www.BidaBing.com.
All trademarks acknowledged.
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, BidaBing Corporation, online real estate auctions
Wed, 16 Apr 2008 07:58:54 GMT
|
